Astrazeneca Pharma India Ltd. (ASTRAZEN) Share Price Hits Fresh 52-Week Low at Rs 7,550
- August 19, 2026
- Posted by: Harsh Piplani
- Category: News
Astrazeneca Pharma India Ltd. fell to Rs 7,550, down 1.31% today, marking a fresh 52-week low. The stock’s market capitalisation stood at Rs 19,124.63 crore.
Astrazeneca Pharma India Ltd. Share Price fell to Rs 7,550 on 19 August 2026, down 1.31% from the previous close of Rs 7,649.85, and in the process touched a fresh 52-week low. With a market capitalisation of Rs 19,124.63 crore, the stock has moved into focus in today’s Stock Market Today and Share Market Today screens because a one-year low often draws attention from traders tracking price action as well as investors reviewing valuation and profitability.
The verified data confirms the price event clearly: Astrazeneca Pharma India Ltd. Share Price opened at Rs 7,610.25, traded as high as Rs 7,648.95, and slipped to an intraday low of Rs 7,550, which also matched its 52-week trough. Turnover stood at Rs 0.12 crore with current volume of 158 shares. The supplied data confirms the fall and the fresh yearly low, but it does not establish a company-specific catalyst behind the move.
Why is the stock trending in Astrazeneca Pharma India Ltd. Stock News and Astrazeneca Pharma India Ltd. News Today searches? The answer is straightforward: the stock has entered the 52 Week Low Stocks list, the current price is sitting at the new one-year low, and the valuation and return ratios now invite closer comparison with the wider Healthcare basket. For investors following Astrazeneca Pharma India Ltd. Share Price Today, the next things to monitor are whether the stock remains around this 52-week trough, how participation evolves from here, and how its valuation and return profile compare with sector and peer benchmarks tracked by Univest.
Astrazeneca Pharma India Ltd. Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 7,550 |
| Previous Close | Rs 7,649.85 |
| Today's Change | Rs -99.85 (-1.31%) |
| Day Open | Rs 7,610.25 |
| Fresh 52-Week Low | Rs 7,550 |
| Day High | Rs 7,648.95 |
| Current Volume | 158 |
| Turnover | Rs 0.12 crore |
| Market Capitalisation | Rs 19,124.63 crore |
Astrazeneca Pharma India Ltd. (ASTRAZEN) traded at Rs 7,550. versus the previous close of Rs 7,649.85, a fall of 1.31%. The stock opened at Rs 7,610.25, reached Rs 7,648.95, touched Rs 7,550. Reported volume was 158.
Astrazeneca Pharma India Ltd. Share Price Today shows a weak trading session, with the stock ending up at its day low after opening above that level and failing to revisit the previous close. The move is important because the intraday low of Rs 7,550 also became the new 52-week low.
In absolute terms, the stock declined by Rs 99.85 from the previous close of Rs 7,649.85 to Rs 7,550. The day’s opening level was Rs 7,610.25, while the day high was Rs 7,648.95. That intraday structure indicates the stock traded close to the prior close early in the session but weakened later, with selling pressure pushing it to the day low. For Astrazeneca Pharma India Ltd. Share News and Astrazeneca Pharma India Ltd. Share Price Update searches, that pattern matters because it suggests the market did not sustain higher intraday levels.
The current volume of 158 shares and turnover of Rs 0.12 crore show the day’s participation in verifiable terms, although the supplied data does not provide an average volume benchmark for a broader volume analysis. Even so, the combination of a negative day change, a close at the intraday low, and a fresh yearly low is enough to keep the stock among market movers and Stocks in News.
For traders and investors monitoring Astrazeneca Pharma India Ltd. Share Price Live on the NSE and BSE, today’s session establishes a clear reference point: Rs 7,550 is now the latest 52-week low and a near-term level the market will continue to watch. From here, the more useful question shifts from intraday price action to whether the stock’s fundamental profile supports continued investor attention.
Astrazeneca Pharma India Ltd. (ASTRAZEN) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 19,124.63 crore |
| P/E Ratio | 51.17x |
| P/B Ratio | 2.03x |
| ROE | -0.78% |
| ROCE | 8.31% |
Astrazeneca Pharma India Ltd. was valued at a P/E ratio of 51.17x, a P/B ratio of 2.03x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.
Profitability and capital efficiency were represented by ROE of -0.78% and ROCE of 8.31%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Benchmark Scope | same sector |
| Company P/E Ratio | 51.17x |
| Benchmark Median P/E | 20.79x |
| Benchmark Average P/E | 47.16x |
| Benchmark P/E Range | 0x to 1,635.98x |
| Company P/B Ratio | 2.03x |
| Benchmark Median P/B | 1.9x |
| Company ROE | -0.78% |
| Benchmark Median ROE | 11.09% |
| Company ROCE | 8.31% |
| Benchmark Median ROCE | 13.29% |
| Company Market Capitalisation | Rs 19,124.63 crore |
| Benchmark Median Market Cap | Rs 134.22 crore |
Astrazeneca Pharma India Ltd. (ASTRAZEN) is classified under sector: Healthcare.
Astrazeneca Pharma India Ltd. (ASTRAZEN) has a P/E ratio of 51.17x, which is above the benchmark median of 20.79x, a difference of +146.13%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Astrazeneca Pharma India Ltd. (ASTRAZEN) has a ROE of -0.78%, which is below the benchmark median of 11.09%, a difference of -107.03%. Astrazeneca Pharma India Ltd. (ASTRAZEN) has a ROCE of 8.31%, which is below the benchmark median of 13.29%, a difference of -37.47%.
Track stocks falling to yearly lows through the Univest 52-week-low screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Ind-Swift Laboratories Ltd. | INDSWFTLAB | 2,724.51 | 51.17 | 2.03 | -0.78 | 8.31 |
| Beta Drugs Ltd. | BETA | 2,697.08 | 62.93 | 9.96 | 18.65 | 22.17 |
| Dr Agarwals Eye Hospital Ltd. | DRAGARWQ | 2,583.65 | 33.9 | 6.99 | 36.29 | 42.4 |
| Sai Parenteral's Ltd. | SAIPARENT | 2,431.62 | 167.79 | 3.07 | 13.9 | 12.97 |
| Fredun Pharmaceuticals Ltd. | FREDUN | 2,403.56 | 54.45 | 8.13 | 11.42 | 13.15 |
Astrazeneca Pharma India Ltd. (ASTRAZEN) has a P/E ratio of 51.17x compared with the displayed peer median of 54.45x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of -0.78% compares with a peer median of 13.9% across the companies shown in the table. ROCE stood at 8.31% versus the displayed peer median of 13.15%, providing a capital-efficiency comparison. Astrazeneca Pharma India Ltd. (ASTRAZEN) has a market capitalisation of Rs 19,124.63 crore. Among the 5 peers shown, 0 have a larger market capitalisation.
Why Investors Are Watching Astrazeneca Pharma India Ltd.
Astrazeneca Pharma India Ltd. Share Price is attracting attention because the stock has combined a fresh 52-week low with a valuation and profitability profile that is open to interpretation against sector and peer benchmarks. That keeps the stock relevant in Stock Updates and Market News screens.
- Fresh price event: the stock fell 1.31% to Rs 7,550 and marked a new 52-week low, which also matched the day low.
- Intraday weakness: after opening at Rs 7,610.25 and trading up to Rs 7,648.95, the stock slipped lower through the session.
- Valuation context: the P/E of 51.17 is above the Healthcare sector median of 20.79 and average of 47.16, while P/B of 2.03 is near the sector middle.
- Profitability context: ROE of -0.78 and ROCE of 8.31 are below sector medians of 11.09 and 13.29 respectively.
- Scale versus peers: market capitalisation of Rs 19,124.63 crore is substantially higher than the supplied peer group, making relative returns and valuation worth monitoring on Univest.
About Astrazeneca Pharma India Ltd.
Astrazeneca Pharma India Ltd. is a listed company tracked on the Indian Stock Market under the symbol ASTRAZEN. In the supplied verified data, the company is placed within the Healthcare sector. That sector classification is useful because it allows investors to compare the stock’s valuation, return ratios and market capitalisation against a broad same-sector benchmark.
For Astrazeneca Pharma India Ltd. Stock News readers, the immediate company context available in the supplied dataset is market-based rather than descriptive. The stock currently carries a market capitalisation of Rs 19,124.63 crore and is being assessed against 196 Healthcare companies in the benchmark universe. Its appearance in today’s 52 Week Low Stocks screens reflects market performance rather than any separately supplied company announcement.
As a result, Astrazeneca Pharma India Ltd. Share Price remains the main point of focus in the current update. Investors following Astrazeneca Pharma India Ltd. Latest News are likely to look at how the stock behaves around the new one-year low, and how its P/E, P/B, ROE and ROCE compare with the wider Healthcare sector and the listed peers shown in Univest data.
Track Astrazeneca Pharma India Ltd. Share Price on Univest
Use Astrazeneca Pharma India Ltd. (ASTRAZEN) live share-price page, Univest 52-week-low screener, Univest market blogs to review live stock data, yearly-low lists and related market analysis.
Investors can track Astrazeneca Pharma India Ltd. Share Price on Univest for live market moves, 52-week levels, share price changes, valuation ratios, sector comparisons and peer data in one place. For users following Astrazeneca Pharma India Ltd. Share Price Today, Astrazeneca Pharma India Ltd. Stock News and Astrazeneca Pharma India Ltd. Shareholding Pattern-related updates, Univest helps organise verified market information into a single view.
That includes daily price action such as current price, previous close, intraday range, turnover and volume, alongside Fundamental Analysis markers including Market Cap, P/E Ratio, P/B Ratio, ROE and ROCE. When a stock appears in screens such as Stocks at 52 Week Low, Top Losers Today or broader Market Movers, that structured view can help investors monitor the data points that are actually verified.
For Astrazeneca Pharma India Ltd. Share Price Live tracking, Univest also provides a practical framework for comparing the company with Healthcare benchmarks and listed peers without turning the analysis into a recommendation. In a session like this, where the stock has moved to a fresh 52-week trough, that context becomes especially relevant.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
What is the latest Astrazeneca Pharma India Ltd. Share Price today?
Ans. Astrazeneca Pharma India Ltd. Share Price Today was Rs 7,550 in the supplied market data. The stock was down 1.31% for the session, or Rs 99.85, compared with the previous close of Rs 7,649.85.
Why is Astrazeneca Pharma India Ltd. Share Price in focus today?
Ans. The stock is in focus because it touched a fresh 52-week low of Rs 7,550 during the session. That one-year low, along with a 1.31% daily decline, has pushed the stock into active market watchlists.
Did Astrazeneca Pharma India Ltd. hit a new 52-week low?
Ans. Yes, the supplied data shows Astrazeneca Pharma India Ltd. touched a fresh 52-week low at Rs 7,550. That level also matched the day’s low, making it the key reference point from today’s trading session.
What were the day open, high and low for Astrazeneca Pharma India Ltd.?
Ans. The stock opened at Rs 7,610.25, moved up to an intraday high of Rs 7,648.95 and slipped to a low of Rs 7,550. Those levels show the session weakened after trading near the previous close.
How much market capitalisation does Astrazeneca Pharma India Ltd. have?
Ans. Astrazeneca Pharma India Ltd. had a market capitalisation of Rs 19,124.63 crore in the supplied data. That is far above the Healthcare sector benchmark median of Rs 134.22 crore and average of Rs 465.93 crore.
What do the valuation ratios show for Astrazeneca Pharma India Ltd.?
Ans. The stock was valued at a P/E ratio of 51.17 and a P/B ratio of 2.03. Its P/E is above the Healthcare sector median of 20.79, while its P/B is only slightly above the median of 1.9.
How profitable is Astrazeneca Pharma India Ltd. based on the supplied data?
Ans. The supplied profitability ratios show ROE at -0.78 and ROCE at 8.31. Both figures are below the Healthcare sector medians of 11.09 for ROE and 13.29 for ROCE, indicating weaker relative returns.
How does Astrazeneca Pharma India Ltd. compare with Healthcare peers?
Ans. Astrazeneca Pharma India Ltd. has a much larger market capitalisation than the supplied peers, but its ROE and ROCE are lower than most of them. Its P/E of 51.17 sits above some peers and below others.
What was the trading volume and turnover in Astrazeneca Pharma India Ltd. today?
Ans. The supplied market data shows current volume of 158 shares and turnover of Rs 0.12 crore. Combined with the fresh 52-week low, those figures help define today’s trading activity in the stock.
What should investors monitor next in Astrazeneca Pharma India Ltd. Stock News?
Ans. Investors may monitor whether Astrazeneca Pharma India Ltd. holds around the new 52-week low of Rs 7,550, and how its valuation and return ratios compare with sector benchmarks and listed Healthcare peers.
